MedPath
TGA Approval

ONTRUZANT trastuzumab 150 mg powder for injection vial (298457)

298457

ONTRUZANT trastuzumab 150 mg powder for injection vial

Samsung Bioepis AU Pty Ltd

January 9, 2019

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/44741374cf8dfa5b50a3bb4d786be269.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/fbbb03dae7ddfe35f040a69db07cbed8.pdf

Active Ingredients

Trastuzumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ONTRUZANT trastuzumab 150 mg powder for injection vial (298457) - TGA 批准文号 | MedPath